Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | GNTA | QNCX | ||
| Company | Orphazyme A/S ADR | Genenta Science S.P.A. ADR | Quince Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9060 | 1.3300 | 29.17 | ||
| High | 0.9571 | 1.3500 | 30.32 | ||
| Low | 0.8457 | 1.3000 | 28.55 | ||
| Last | 0.8700 | 1.3100 | 29.54 | ||
| Change | -0.0200 | -0.0200 | +0.66 | ||
| Percent Change | -2.25% | -1.50% | +2.29% | ||
| Volume | 941,400 | 55,400 | 26,100 | ||
| 20-Day Average Volume | 1,980,090 | 79,200 | 40,095 | ||
| Previous | 0.8900 | 1.3300 | 28.88 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 1.4725 | 20.95 | ||
| 20-Day Raw Stochastic | 41.76% | 22.00% | 94.46% | ||
| 20-Day Relative Strength | 36.52 | 44.92 | 71.31 | ||
| Weighted Alpha | -87.89 | -74.71 | -42.78 | ||
| Today's Opinion | 100% Sell | 8% Buy | 24% Sell | ||
| Yesterday's Opinion | 100% Sell | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | -13.25% since 07/30/26 | +28.27% since 07/30/26 | ||
| Low | 0.8275 on 03/29/22 | 1.2000 on 08/04/26 | 21.55 on 07/31/26 | ||
| High | 0.9600 on 03/29/22 | 1.5700 on 08/03/26 | 30.32 on 08/06/26 | ||
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -22.02% since 07/06/26 | +73.97% since 07/06/26 | ||
| Low | 0.5101 on 03/14/22 | 1.2000 on 08/04/26 | 16.23 on 07/14/26 | ||
| High | 1.3720 on 03/10/22 | 1.7000 on 07/22/26 | 30.32 on 08/06/26 | ||
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | +89.88% since 05/06/26 | +21.07% since 05/06/26 | ||
| Low | 0.5101 on 03/14/22 | 0.5500 on 05/26/26 | 15.10 on 07/01/26 | ||
| High | 2.7500 on 01/03/22 | 2.5800 on 06/02/26 | 30.32 on 08/06/26 | ||
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +78.96% since 02/06/26 | +6.18% since 02/06/26 | ||
| Low | 0.5101 on 03/14/22 | 0.5500 on 05/26/26 | 15.10 on 07/01/26 | ||
| High | 5.4900 on 10/13/21 | 2.5800 on 06/02/26 | 196.02 on 02/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 30,904 | 30,045 | ||
| Shares Outstanding, K | 35,312 | 23,591 | 1,017 | ||
| Annual Sales, $M | 0 | 0 | 0 | ||
| Annual Net Income, $M | -97,010,000 | -7,390,000 | -83,980,000 | ||
| Last Qtr Sales, $M | N/A | N/A | 0 | ||
| Last Qtr Income, $M | N/A | N/A | 35,910,000 | ||
| 60-Month Beta | 1.68 | 0.77 | 1.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -11.80 on 05/11/26 | ||
| Latest Earnings Date | 04/05/22 | 04/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||